Vasoptic Medical Receives Abell Foundation Investment and Moves Headquarters to Baltimore

August 7, 2015

 

FOR IMMEDIATE RELEASE

 

Baltimore, MD (August 6, 2015)—Vasoptic Medical, Inc., a Maryland-based medical device company, announced today that they have received investment from the Abell Foundation to support the development of Vasoptic’s vascular imaging technology. In conjunction with the investment, the company has moved its headquarters to the McHenry Row area of Locust Point in Baltimore.

 

For full press release click here.

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 15, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 25, 2017

Early Detection: New Device Measures Risk of Blindness from Diabetes

October 7, 2016

1/10
Please reload

© 2020 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230